3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Unknown
1
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pathologic Complete Response
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Blood Specimen Collection
85
Surveys and Questionnaires
83
Surgical Procedures, Operative
44
Drug Therapy
32
Radiotherapy
27
Biopsy
26
Amplified Fragment Length Polymorphism Analysis
24
Neoadjuvant Therapy
23
Immunohistochemistry
22
Gene Expression Profiling
21
Bevacizumab
19
Data Collection
18
Immunotherapy
17
Ultrasonography
16
Positron Emission Tomography Computed Tomography
16
Magnetic Resonance Spectroscopy
16
Liquid Biopsy
16
pembrolizumab
15
Nivolumab
15
Watchful Waiting
14
Radiosurgery
14
Observation
14
Microarray Analysis
14
Magnetic Resonance Imaging
14
Interviews as Topic
14
Immune Checkpoint Inhibitors
13
Colonoscopy
13
Capecitabine
13
Polymerase Chain Reaction
12
Paclitaxel
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Observational
×
Dynamic Contrast Enhanced Magnetic Resonance Imaging
×
Clear all
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled